Researchers uncover new disease-linked microbial species through pan-body microbiome analysis

Researchers in Germany conducted a pan-body microbiome analysis, uncovering new microbial species and potential therapies linked to diseases, with implications for diagnostic and therapeutic advancements.

Bicycle Therapeutics stock sinks following release of topline data, post-hoc analyses

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 14, 2024

Tennessee tries to rein in Ballad’s hospital monopoly after years of problems

Ballad Health, an Appalachian company with the nation’s largest state-sanctioned hospital monopoly, may soon be required to improve its quality of care or face the

September 18, 2024

Benefits of Myeloma Regimens in the Real World Fall Well Short of Trials

SAN DIEGO — Multiple myeloma patients in the clinic appear to benefit far less from standard treatments when compared with how the same regimens performed

December 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.